Evidence map›Paper›PMID 33751496›Full record

ArticleJournal of nephrology2021

Atypical hemolytic uremic syndrome due to DGKE mutation and response to eculizumab: lessons for the clinical nephrologist.

Danya Husain, Brian Barron, Anya Golkowski Barron, Ibrahim Sandokji, Olivera Marsenic, Jillian K Warejko

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Danya HusainPediatric Nephrology, Department of Pediatrics, Yale University School of Medicine, P.O. Box 208064, New Haven, CT, 06520-8064, USA.
Brian BarronYale University School of Medicine, New Haven, CT, USA.
Anya Golkowski BarronYale University School of Medicine, New Haven, CT, USA.
Ibrahim SandokjiPediatric Nephrology, Department of Pediatrics, Yale University School of Medicine, P.O. Box 208064, New Haven, CT, 06520-8064, USA.
Olivera MarsenicPediatric Nephrology, Lucile Packard Children's Hospital, Stanford University School of Medicine, Stanford, USA.
Jillian K WarejkoPediatric Nephrology, Department of Pediatrics, Yale University School of Medicine, P.O. Box 208064, New Haven, CT, 06520-8064, USA. Jillian.warejko@yale.edu.
Yale University · USLucile Packard Children's Hospital · USTaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atypical Hemolytic Uremic SyndromeAntibodies, Monoclonal, HumanizedDiacylglycerol KinaseHumansInfantMaleMutationNephrologistsAntibodies, Monoclonal, HumanizedDGKE protein, humanDiacylglycerol KinaseeculizumabAtypical hemolytic uremic syndrome (aHUS)ComplementComplement inhibitorsGeneticsPediatrics

Identifiers

PMID33751496
OpenAlexW3137459210

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.